EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features

Giovanna Giordano iD, Elena Ferioli iD, Debora Guareschi, Alessandro Tafuni iD

Cancers · 26.10.2023 · 15 (21) · 5155

DOI: 10.3390/cancers15215155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.10.2023. Verfasst von Giovanna Giordano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, Pathology Unit, University of Parma, Viale A. Gramsci, 14, 43126 Parma, Italy. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dedifferentiated endometrioid adenocarcinoma is characterised by the coexistence of an undifferentiated carcinoma and a low-grade endometrioid adenocarcinoma. The low-grade component in this subtype of endometrial carcinoma is Grade 1 or 2 according to the Federation of Gynaecology and Obstetrics (FIGO) grading system. The coexistence of low-grade endometrial carcinoma and solid undifferentiated carcinoma can cause diagnostic problems on histological examination. In fact, this combination can often be mistaken for a more common Grade 2 or Grade 3 endometrial carcinoma. Therefore, this subtype of uterine carcinoma can often go under-recognised. An accurate diagnosis of dedifferentiated endometrial carcinoma is mandatory because of its poorer prognosis compared to Grade 3 endometrial carcinoma, with a solid undifferentiated component that can amount to as much as 20% of the entire tumour. The aim of this review is to provide clinical, immunohistochemical, and molecular data to aid with making an accurate histological diagnosis and to establish whether there are any findings which could have an impact on the prognosis or therapeutic implications of this rare and aggressive uterine neoplasm.

Schlagwörter

Stichwörter der Autor:innen

DNA Polymerase Epsilon (POLE)Switch/Sucrose Non-Fermentable (SWI/SNF) complexTp53 mutationsendometrial dedifferentiated/undifferentiated carcinomaimmune checkpoint inhibitorsmismatch repair (MMR) gene mutationsthe Cancer Genome Atlas (TCGA) Research Network

Autor:innen und Institutionen

  • Department of Medicine and Surgery, Pathology Unit, University of Parma, Viale A. Gramsci, 14, 43126 Parma, Italy.

ORCID-Profile: Giovanna Giordano, Elena Ferioli, Alessandro Tafuni

Zitieren

APA

Giordano, G., Ferioli, E., Guareschi, D., & Tafuni, A. (2023). Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features. Cancers, 15(21), 5155. https://doi.org/10.3390/cancers15215155

Vancouver

Giordano G, Ferioli E, Guareschi D, Tafuni A. Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features. Cancers. 2023;15(21):5155. doi:10.3390/cancers15215155

BibTeX
@article{Giordano2023,
  author = {Giordano, Giovanna and Ferioli, Elena and Guareschi, Debora and Tafuni, Alessandro},
  title = {Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {21},
  pages = {5155},
  doi = {10.3390/cancers15215155}
}
Kostenlos starten →